Fluidigm Takes a Loss in Patent Suit After ‘Showdown’ Defeat – Bloomberg Law
Fluidigm Takes a Loss in Patent Suit After ‘Showdown’ Defeat Bloomberg Law
Archive for February, 2021
-
In: PATENT NEWS
-
In: PATENT NEWS
Fluidigm Takes a Loss in Patent Suit After ‘Showdown’ Defeat
IP Law News. The parties said that under a judge’s interpretation of a key term in …
-
In: PATENT NEWS
Fluidigm Takes a Loss in Patent Suit After ‘Showdown’ Defeat
Fluidigm Takes a Loss in Patent Suit After ‘Showdown’ Defeat · More from Bloomberg Law.
-
In: PATENT NEWS
Nemesis System: WB’s Patent Will Only Make Video Games Worse – Screen Rant
Nemesis System: WB’s Patent Will Only Make Video Games Worse Screen Rant
-
In: The IPKat BLOG
[Guest post] Here we draw again: the never-ending debate around street art and its removal
http://ipkitten.blogspot.com/2021/02/guest-post-here-we-draw-again-never.html The IPKat is pleased to host the following guest post by Federica Pezza (Hogan Lovells) on copyright protection of street art and the consequences of unauthorised destruction thereof. Here’s what Federica writes: Here we draw again: the never-ending debate around street art and its removal by Federica Pezza Spain,... Continue reading
-
In: PATENT NEWS
CAFC Patent Cases – February 2021 #2 | WilmerHale – JDSupra – JD Supra
CAFC Patent Cases – February 2021 #2 | WilmerHale – JDSupra JD Supra
-
In: PATENT NEWS
Copy Cats II: Nexus of Copying Required to Substantiate Non-Obviousness
Because the Patent Trial and Appeal Board (PTAB) in Liqwd failed to weigh this evidence as an indicium of non-obviousness, the Federal Circuit …
-
In: PATENT NEWS
Can a Patentee Unilaterally Moot an Accused Infringer’s Appeal?
Several months later, ABS filed a petition for inter partes review of the ‘161 Patent, to which the Patent Trial and Appeal Board (“Board”) instituted …
-
In: PATENT NEWS
Jonathan Barnett on Competition Regulators and Standard-Essential Patents – Center for the …
The following post comes from Connor Sherman, a 2L at Scalia Law and a Research Assistant at CPIP. By Connor Sherman The field of intellectual …
-
In: PATENT NEWS
US vs China: Goodwin Attorneys Discuss Patent Hurdles and Adalimumab Marketing
Huiya Wu, JD, and Freddy Yip, PhD, PCLL, attorneys at Goodwin Procter, discussed biologic drug patent laws in China and the US.